These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

334 related articles for article (PubMed ID: 38690727)

  • 1. Complement regulation in the eye: implications for age-related macular degeneration.
    Wilke GA; Apte RS
    J Clin Invest; 2024 May; 134(9):. PubMed ID: 38690727
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The eye as a complement dysregulation hotspot.
    Clark SJ; Bishop PN
    Semin Immunopathol; 2018 Jan; 40(1):65-74. PubMed ID: 28948331
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of complement system in ocular diseases including uveitis and macular degeneration.
    Jha P; Bora PS; Bora NS
    Mol Immunol; 2007 Sep; 44(16):3901-8. PubMed ID: 17768108
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The link between morphology and complement in ocular disease.
    Mohlin C; Sandholm K; Ekdahl KN; Nilsson B
    Mol Immunol; 2017 Sep; 89():84-99. PubMed ID: 28622910
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Age-related macular degeneration and the complement system.
    Khandhadia S; Cipriani V; Yates JR; Lotery AJ
    Immunobiology; 2012 Feb; 217(2):127-46. PubMed ID: 21868123
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Complement system and age-related macular degeneration: drugs and challenges.
    Wu J; Sun X
    Drug Des Devel Ther; 2019; 13():2413-2425. PubMed ID: 31409975
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Parainflammation, chronic inflammation, and age-related macular degeneration.
    Chen M; Xu H
    J Leukoc Biol; 2015 Nov; 98(5):713-25. PubMed ID: 26292978
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular Mechanisms of Complement System Proteins and Matrix Metalloproteinases in the Pathogenesis of Age-Related Macular Degeneration.
    Mansoor N; Wahid F; Azam M; Shah K; den Hollander AI; Qamar R; Ayub H
    Curr Mol Med; 2019; 19(10):705-718. PubMed ID: 31456517
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Challenges and Promise of Complement Therapeutics for Ocular Diseases.
    Park DH; Connor KM; Lambris JD
    Front Immunol; 2019; 10():1007. PubMed ID: 31156618
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The complement system and age-related macular degeneration.
    Sivaprasad S; Chong NV
    Eye (Lond); 2006 Aug; 20(8):867-72. PubMed ID: 16410816
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The complement system in age-related macular degeneration.
    Armento A; Ueffing M; Clark SJ
    Cell Mol Life Sci; 2021 May; 78(10):4487-4505. PubMed ID: 33751148
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Complement System and Potential Therapeutics in Age-Related Macular Degeneration.
    Park YG; Park YS; Kim IB
    Int J Mol Sci; 2021 Jun; 22(13):. PubMed ID: 34202223
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A renewed appreciation for ocular immune privilege.
    Niederkorn JY
    Arch Soc Esp Oftalmol; 2005 Aug; 80(8):437-8; 439-40. PubMed ID: 16136394
    [No Abstract]   [Full Text] [Related]  

  • 14. Targeting the complement system for the management of retinal inflammatory and degenerative diseases.
    Xu H; Chen M
    Eur J Pharmacol; 2016 Sep; 787():94-104. PubMed ID: 26948311
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inherited complement regulatory protein deficiency predisposes to human disease in acute injury and chronic inflammatory statesthe examples of vascular damage in atypical hemolytic uremic syndrome and debris accumulation in age-related macular degeneration.
    Richards A; Kavanagh D; Atkinson JP
    Adv Immunol; 2007; 96():141-77. PubMed ID: 17981206
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Complement Inhibitors in Age-Related Macular Degeneration: A Potential Therapeutic Option.
    Qin S; Dong N; Yang M; Wang J; Feng X; Wang Y
    J Immunol Res; 2021; 2021():9945725. PubMed ID: 34368372
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Decreased membrane complement regulators in the retinal pigmented epithelium contributes to age-related macular degeneration.
    Ebrahimi KB; Fijalkowski N; Cano M; Handa JT
    J Pathol; 2013 Apr; 229(5):729-42. PubMed ID: 23097248
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Complement system in pathogenesis of AMD: dual player in degeneration and protection of retinal tissue.
    Kawa MP; Machalinska A; Roginska D; Machalinski B
    J Immunol Res; 2014; 2014():483960. PubMed ID: 25276841
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The case for complement and inflammation in AMD: open questions.
    Karagianni N; Adamis AP
    Adv Exp Med Biol; 2010; 703():1-7. PubMed ID: 20711703
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Age-related macular degeneration and the role of the complement system.
    McHarg S; Clark SJ; Day AJ; Bishop PN
    Mol Immunol; 2015 Sep; 67(1):43-50. PubMed ID: 25804937
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.